Cepheid (NASDAQ:CPHD) rose 52.61% during previous trade. Piper Jaffray issued rating on the stock of Cepheid (NASDAQ:CPHD) in a research note issued to investors on Sep-06-16, the stock received “Downgrade” rating from Overweight to Neutral. Additionally Needham issued their Verdict on the stock of the company, on record date of Sep-06-16 the stock was “Downgraded” from Buy to Hold besides that on Sep-06-16 Cepheid (NASDAQ:CPHD) was “Downgraded” by Craig Hallum from Buy to Hold. Furthermore on Apr-14-16 the stock was “Reiterated” by Canaccord Genuity as Hold from $29 to $34.
Cepheid (NASDAQ:CPHD) shares ended last trading session at the price of $52.53 whereas a number of traders indicating mean target price will hit $39.83 over the next twelve months, mean value of price target most recently revised on 08/19/16. Cepheid (NASDAQ:CPHD)’s highest estimates of price target are $47.00 and low forecast is $30.00 based on the opinion of 15 analysts. The price target estimates represents a standard deviation of 5.22. However brokerage recommendations suggests an ABR of 2.07 based on calls of 14 experts, where 6 brokers polls the stock a Strong Buy, 1 suggest the stock a Buy, 7 suggest Hold, 0 are rating the stock as Sell while 0 as Strong Sell.
Cepheid (NASDAQ:CPHD) is expected to release the earnings of its current quarter on 10/18/16. The company is expected to release $0.03 EPS for current quarter according to 16 analysts whereas the company reported $-0.32 EPS during same quarter a year ago. For the current quarter the stock has a lowest EPS estimates of $0.00 and high estimate of $0.08. For the current year Cepheid (NASDAQ:CPHD) has set to release EPS of $0.33 as per the sentiments of 16 analysts, however according to 16 analysts, the company expected to release $1.05 EPS for next year.
Cepheid (NASDAQ:CPHD)’s average revenue estimates for the current quarter are $154.16M according to 18 number of analysts. However its lowest revenue estimates are $149M and highest revenue estimates are $161M. A year ago the company’s sales were $126.47M. Its yearly sales growth estimates are 21.90%. For the next quarter the company has anticipated average revenues of $177.14M, according to the sentiments of 18 analysts. For the current year the company has fixed $622.14M revenues, as per the opinion of 19 analysts. For the current year the company has low revenue estimates of $610.8M in contradiction of high revenue estimates of $628.08M. Whereas for the next year revenues are set at $710.71 by 19 analysts.
The stock exchanged hands 31.70M shares versus average trading capacity of 740,887.00 shares, while its shares’ total market worth is $3.85B along with 73.01M outstanding shares. Cepheid (NASDAQ:CPHD) shares were trading -1.24% below from the 52-week high price mark of $53.19 and +109.37% above from the 52-week price bottom of $25.09. However the company observed 52 week high price on 09/17/15 and witnessed 52 week low price on 05/06/16. The company’s price sits 54.76% above from its 50-day moving average of $34.93 and 63.15% far from the stock’s 200-day moving average which is $31.90. Cepheid (NASDAQ:CPHD)’s price to sales ratio for trailing twelve month stands at 6.77, whereas its price to book ratio for most recent quarter sits at 10.14. However the company’s price to cash per share for most recent quarter stands at 11.85.